Delivery Order SPE2DR25D2205-SPE2DR26F2L26
Award Date 3/19/26
Potential Completion Date 4/9/26
Potential Value $2.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,754.28 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for Hemangeol 4.28 mg/ml oral solution 120 ml. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 and running through December 2026. This vehicle supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm...
- The Defense Logistics Agency issued a $1,315.71 delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for HEMANGEOL 4.28 mg/mL oral solution 120 mL, with an ultimate completion date of March 31, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999 through December 2026), which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Hemangeol 4.28 mg/ml oral solution (120ml), with a contract ceiling value of $2,662.56 and an ultimate completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,631.42 to AmerisourceBergen Drug Corp for the supply of Hemangeol 4.28 mg/ml oral solution (120 ml) on January 15, 2026, with an ultimate completion date of February 6, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal...
- On January 29, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,631.42 to AmerisourceBergen Drug Corp for the supply of Hemangeol 4.28 mg/ml oral solution (120ml). This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order is scheduled for completion by February 20, 2026, with performance occurring at the contractor's...
- The Defense Logistics Agency awarded a $366,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120ml bottles of 4.28mg/ml oral solution of HEMANGEOL. As the prime contractor, Amerisourcebergen will deliver the pediatric medication to a facility in Conshohocken, Pennsylvania by September 8, 2023 in support of the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified. The delivery order was issued under an existing...
- The Defense Logistics Agency Troop Support Medical awarded a $2,196.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to supply 120mL bottles of 4.28 mg/mL oral solution of HEMANGEOL. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from September 18, 2023 to October 10, 2023. No subcontractors or set aside designations were indicated. The Defense...
- The Defense Logistics Agency awarded a $2,196.60 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 120ml bottles of 4.28 mg/ml oral solution of HEMANGEOL. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from August 2, 2023 through August 23, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency is the logistics combat...
- The Defense Logistics Agency Troop Support Medical awarded a $1,098.30 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562150405 HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The place of performance will be Conshohocken, Pennsylvania, with work scheduled to be completed by October 2, 2023 after starting on September 11, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other...
- This is a Delivery Order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract has a ceiling value of $1,263.27 and is a Firm Fixed Price contract type. It is not a set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F2L26Delivery Order
The Defense Logistics Agency issued a $2,192.85 delivery order to Amerisourcebergen Drug Corp on March 19, 2026, for Hemangeol 4.28 mg/ml oral solution 120 ml, with an ultimate completion date of April 9, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis and carries no set-aside. The parent vehicle is an Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs.
Generated 6/18/26, 10:34 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 3/18/26 |